Back
 
China Launches 3 Remdesivir Trials
Mild/Moderate 2019-nCoV Remdesivir RCT
https://clinicaltrials.gov/ct2/show/NCT04252664?cond=remdesivir&draw=2&rank=2
Severe 2019-nCoV Remdesivir RCT
https://clinicaltrials.gov/ct2/show/NCT04257656?cond=remdesivir&draw=2&rank=1
View Older Articles
Back to Top
www.natap.org